Studies have suggested that neoantigens presentation in tumours promotes the release of IFN-γ from tumour-infiltrating lymphocytes (TILs), and the released IFN-γ upregulates PD-L1 expression in immune cells and tumours [46, 47]. Here, IFNG is linked to neoplasm.